Anixa Biosciences (ANIX) Income from Non-Controlling Interests (2018 - 2026)
Anixa Biosciences' Income from Non-Controlling Interests was -$19,000 in fiscal Q3 2026 (quarter ended Jul 31, 2026), compared with -$22,000 a year earlier.
Powered by 
Analysis
Anixa Biosciences (ANIX) Income from Non-Controlling Interests (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Anixa Biosciences' Income from Non-Controlling Interests was -$88,000 through Jul 31, 2026; for FY2025 (ended Oct 31, 2025), it came in at -$101,000.
- In earlier fiscal years, Income from Non-Controlling Interests was -$144,000 in FY2024, -$119,000 in FY2023, -$176,000 in FY2022 and -$174,000 in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Anixa Biosciences | 102.02 Mn | 100.75 Mn | - | -19,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -19,000.00 |
| Apr 30, 2026 | -20,000.00 |
| Oct 31, 2025 | -27,000.00 |
| Jul 31, 2025 | -22,000.00 |
| Apr 30, 2025 | -23,000.00 |
| Jan 31, 2025 | -29,000.00 |
| Oct 31, 2024 | -30,000.00 |
| Jul 31, 2024 | -38,000.00 |
| Apr 30, 2024 | -41,000.00 |
| Jan 31, 2024 | -35,000.00 |
| Oct 31, 2023 | -31,000.00 |
| Jul 31, 2023 | -37,000.00 |
| Apr 30, 2023 | -19,000.00 |
| Jan 31, 2023 | -32,000.00 |
| Oct 31, 2022 | -53,000.00 |
| Jul 31, 2022 | -29,000.00 |
| Apr 30, 2022 | -44,000.00 |
| Jan 31, 2022 | -50,000.00 |
| Oct 31, 2021 | -58,000.00 |
| Jul 31, 2021 | -54,000.00 |
API Access
Anixa Biosciences Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();